Clin2
NCT00040352Worth exploringRecruiting

Melanoma risk in families and individuals

MelanomaDysplastic Nevus Syndrome

Part of Cancer, Genetic & congenital, Skin clinical trials.

This study looks at people and families with a high risk of melanoma, especially if it runs in the family or is linked to certain genetic conditions. The goal is to better understand what causes melanoma and how to detect it earlier.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
4 weeks to 99 years
Study type
Observational

Who can take part

  • You must be at least 4 weeks old.
  • You or a family member must have a history of melanoma, especially if it was unusual, occurred at a young age, or involved multiple cases in the family.
  • You or a family member must have a known or suspected genetic or congenital condition that increases melanoma risk, such as giant congenital nevi or dysplastic nevi.
  • You or a family member must have a history of certain other cancers or conditions like retinoblastoma, Hodgkin's lymphoma, or an immunodeficiency syndrome.
  • You must be able to provide informed consent yourself or have a legal guardian who can.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02775643Recruiting
Study genes from children’s mole and melanoma samples

This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.

Memphis, Tennessee
NCT05446155Recruiting
Studying test results to predict and diagnose melanoma

This study looks at diagnostic and prognostic factors in people who have suspicious pigmented skin lesions or melanoma that doctors are evaluating with surgery or tissue sampling. It may help improve how clinicians decide what the lesion is and what to expect over time.

Helsingborg, Skåne County
NCT06566404Not yet recruiting
Gene tests and blood test to guide melanoma treatment

This study looks at your melanoma's gene activity and a blood test for tumor DNA to help predict the risk of the cancer coming back. You will need to provide blood and tissue samples, and the goal is to find better ways to personalize treatment for people with thicker, high-risk melanomas.

NCT05350761Recruiting
Study rare tumors and inherited cancer risk in families

This study looks at people who have rare or unusual cancers or who may have an inherited (family) risk for cancer. It helps researchers learn what genetic or other factors might be involved by collecting family history and medical records, including pathology slides.

Bethesda, Maryland
NCT03054584Recruiting
Study the genetics behind common skin moles

This study looks at why some people develop melanocytic nevi (common skin moles) by examining genetic factors. It may help researchers understand the causes of moles and could guide future skin health research.

Sacramento, California
NCT07277920Recruiting
Skin lesion study using special microscope and genetics

This study looks at skin spots that might be unusual moles or early melanoma using a special microscope that sees deep into the skin. It aims to match these microscope images with genetic information to better understand these spots.

Modena, Mo

Hear when a new Melanoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.